<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Expression of the Wnt target gene ASCL2 is elevated in 78% of intestinal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> datasets (Oncomine), suggesting a role for deregulated ASCL2 in the aetiology of intestinal <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Furthermore, ectopic expression of Ascl2 has previously been shown to lead to <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> in the mouse </plain></SENT>
<SENT sid="2" pm="."><plain>However, elevated levels of ASCL2 does not have an impact on the overall survival or recurrence-free survival rates in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>Here the authors use a novel mouse model to analyse the role of Ascl2 in intestinal <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e> and address the controversy surrounding the relevance of this gene to the aetiology of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>DESIGN: The authors have generated a mouse possessing a transgene carrying the Ascl2 gene together with its endogenous promoter and regulatory regions, thereby elevating Ascl2 expression in an authentic manner </plain></SENT>
<SENT sid="5" pm="."><plain>The authors have further intercrossed these Ascl2 overexpressers to the classic Apc(Min) model, to study the consequence of elevated Ascl2 expression in intestinal <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Here the authors genetically demonstrate that elevated expression of Ascl2 in a Wnt signalling dependent manner specifically in the stem cell compartment of the intestine neither increases <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> formation nor diminishes survival in a well established <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumour</z:e> model, the Apc(min) mouse </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The authors conclude that ectopic expression of Ascl2 is more important in the aetiology of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> than overexpression of Ascl2 </plain></SENT>
</text></document>